The Recall Desk
HighFDA (Devices)·Z-1419-2021·Announced 2021-04-21

FDA Recalls 222 Units of Covidien Tri-Staple 2.0 Reinforced Intelligent Reloads

FDA is recalling 222 units of Covidien Tri-Staple 2.0 Reinforced Intelligent Reloads due to a potential packaging defect that could compromise sterility and increase infection risk.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a risk-of-harm product (sterility compromise and potential infection) where injury has not yet been reported, fitting the High severity criteria.

Plain-English summary

The U.S. Food and Drug Administration (FDA) is recalling 222 units of the Covidien Tri-Staple 2.0 Reinforced Intelligent Reload 60 mm Medium/Thick. These medical devices are used with the Signia stapling system for various surgical procedures, including abdominal, gynecologic, pediatric, and thoracic surgeries. The specific product number is SIGTRSB60AMT.

The recall is issued because the packaging pouch may contain an extra laminate layer. This defect could compromise the sterility of the device. Additionally, the extra layer may prevent the complete removal of Ethylene Oxide sterilization gas, potentially increasing the risk of patient infection or exposure to retained Ethylene Oxide.

The affected units are distributed in Alabama, Arkansas, Florida, Indiana, Louisiana, Massachusetts, Minnesota, Missouri, New Jersey, New York, Oregon, Pennsylvania, and Texas. The lot number is N0M0801RY, and the expiration date is 11/30/2023. Healthcare facilities and consumers should stop using these devices and contact the manufacturer for further instructions.

The recalled product

Product
Covidien Tri-Staple 2.0 Reinforced Intelligent Reload 60 mm Medium/Thick-For use with Signia stapling system. Staple line reinforcement has applications in abdominal, gynecologic, pediatric and thoracic surgery for resection, transection of tissue and creation of anastomosis. It
Manufacturer
Covidien Llc
Affected units
222

Distribution

Distributed in 13 states: